Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Prostate Cancer
Clinicians need up-to-date information about when and how to use molecular assays to inform individual patient risk; the side effects of ADT and management options for these side effects; and the results of recent clinical trials in the non-metastatic CRPC setting, so that patients can receive optimal care and delay the onset of metastases as long as possible.
Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Prostate Cancer
Clinicians need up-to-date information about when and how to use molecular assays to inform individual patient risk; the side effects of ADT and management options for these side effects; and the results of recent clinical trials in the non-metastatic CRPC setting, so that patients can receive optimal care and delay the onset of metastases as long as possible.
Recent Developments in the Management of Prostate Cancer
Clinicians need up-to-date information on patient selection for active surveillance and the recommended active surveillance protocol, so that appropriate men with prostate cancer can be encouraged to pursue active surveillance and avoid treatment and side effects. In addition, clinicians must be aware of results of recent clinical trials in the non-metastatic CRPC setting, so that patients can receive optimal care and delay the onset of metastases as long as possible.
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Prostate Cancer
During this tumor board, faculty will discuss the emerging role of tumor and germline genetic testing and the treatment of advanced disease.
Expert Insights on New Systemic Therapies for Advanced Prostate Cancer

The goal of this activity is to improve participants’ knowledge of, confidence in, and competence in integrating recent findings into the treatment of patients with prostate cancer.

 

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Prostate Cancer

The Emerging Role of Tumor and Germline Genetic Testing and the Treatment of Advanced Disease

Expert Insights on New Systemic Therapies for Advanced Prostate Cancer

The goal of this activity is to improve participants’ knowledge of, confidence in, and competence in integrating recent findings into the treatment of patients with prostate cancer.

 

NCCN Harmonized Guidelines™ for Sub-Saharan Africa

Clinicians around the world use NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) as a standard for clinical decision-making.  The NCCN Harmonized Guidelines™ are targeted regional resources created as part of a collaborative effort to combat the skyrocketing cancer rate

NCCN Guidelines® Updates: Management of Prostate Cancer
Clinicians need up-to-date information on the role of germline and tumor genetic testing for risk stratification of men with localized prostate cancer so that men with indolent disease, unlikely to affect the patients in their lifetime, can be encouraged to pursue active surveillance and avoid treatment and side effects.
Optimizing the Treatment of Advanced Prostate Cancer: Expert Review of the Latest Data and Guideline Recommendations

The goal of this activity is to increase participants' ability to leverage recent developments in the care of patients with advanced prostate cancer to improve clinical outcomes and quality of life.

Pages

Subscribe to RSS - Prostate Cancer